Form 4: Tenax Therapeutics CFO Buys Shares
Insider Transaction (Form 4)
Thomas R Staab Ii, Chief Financial Officer of Tenax Therapeutics, Inc., purchased 5,675 shares of common stock on September 11, 2026 for $1.94 per share.
Summary
- Open-market purchase: acquired 5,675 Common Stock at $1.94 ($10,981) on September 11, 2026; holds 15,675 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $10,981, committing personal capital to the stock.
Insider Transactions
Thomas R Staab Ii — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Open-market purchase | Common Stock | 5,675 | $2 | $11.0K | 15,675 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Open-market purchase (5,675 shares) |
Keywords
insider transaction, Form 4, TENX, TENAX THERAPEUTICS, INC., bullish, Thomas R Staab Ii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.